Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • Collaborative Medical Oncology Group (CMOG)
  • Medical Oncology Forum (MOF)
  • American Society of Clinical Oncology (ASCO)
  • Languages Spoken

  • Telugu
  • English
  • Hindi
  • Kannada
  • Tamil
  • Field of Expertise

  • Blood cancers (Acute lymphoblastic leukemia, Acute myeloid leukemia, chronic myeloid leukemia, Chronic lymphocytic leukemia), Plasma cell disorders
  • Autologous and Allogeneic stem cell transplants (matched sibling donor, matched/mismatched unrelated donor, haploidentical donor, cord blood transplants). Trained at Vancouver General Hospital, British Columbia that performs more than 300 stem cell transplants a year.
  • Childhood cancers
  • Immunotherapy
  • Targeted therapy
  • Awards & Achievements

  • University Topper (SDUAHER) Internal Medicine (2013).
  • 1st rank DM Medical Oncology Entrance Examination – Nizam’s Institute of Medical Sciences.
  • Oral presentation short-listed for the prestigious best of Annual American Society of Hematology Conference, San Diego, 2016
  • Best poster presentation award at ICON 2016
  • ICON 2017, Lucknow: Quiz (2nd Prize)
  • ISMPO-Torrent Young Scholar Award 2017, entered zonal round, Chennai.
  • Talks & Publications

  • Danthala M, Kallur KG, Prashant GR, Rajkumar K, Rao MR. 177 Lu-DOTATATE therapy in patients with neuroendocrine tumours: 5 years’ experience from a tertiary cancer care centre in India. European journal of nuclear medicine and molecular imaging. 2014 Jul 1;41(7):1319-26.
  • Danthala M, Gundeti S, Kuruva SP, Puligundla KC, Adusumilli P, Karnam AP, Bala S, Konatam ML, Maddali LS, Digumarti RR. Generic imatinib in chronic myeloid leukemia: survival of the cheapest. Clinical Lymphoma Myeloma and Leukemia. 2017 Jul 1;17(7):457-62.
  • Danthala M, Gundeti S, Maddali LS, Pillai A, Puligundla KC, Adusumilli RP. Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care center in India. South Asian journal of cancer. 2016 Oct;5(4):176.
  • Danthala M, Rajesh GR, Gundeti S, Raju GS, Chandran P, Srinivas ML. Obesity and breast cancer: Association of serum adiponectin, leptin, and adiponectin–leptin ratio as risk biomarkers. Indian Journal of Medical and Paediatric Oncology. 2018 Jul 1;39(3):292.
  • Danthala M, Lakshmaiah V. Correlative study of serum cystatin C levels with severity of acute ischemic stroke. Journal of Clinical and Biomedical Sciences J Clin Biomed Sci. 2013;3(4):188-92.
  • Karpurmath SV, Seshachalam A, Selvaraj K, Rajamani P, Reddy N, Malipatil B, Sirigeri R, Prasad K, Reddy K, Danthala M, Udupa KS. Halving time of BCR-ABL1 in Chronic Myeloid Leukemia, Is it a better than day 90 value–Multicenter study from south India. Clinical Lymphoma Myeloma and Leukemia. 2019 Sep 30.
  • Seshachalam A, Karpurmath SV, Rathnam K, Raman SG, Janarthinakani M, Prasad K, Patil C, Anoop P, Reddy N, Anumula SK, Roopa SP, Danthala M. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. Journal of global oncology. 2019 Dec;5:1-3.
  • Adusumilli P, Gundeti S, Danthala M, Pk C. 301P Long term survival and late side effects of paediatric Hodgkin lymphoma patients: a study from tertiary care centre in Southern India. Annals of Oncology. 2015 Dec 1;26(suppl_9):ix89-.
  • Puligundla CK, Gundeti S, Bala S, Pillai A, Adusumilli P, Danthala M, Konatam ML, Maddali LS. Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domain in CML Patients with Imatinib Treatment Failure-Data from a Large Tertiary Center in India. Blood 2016 vol: 128 (22) pp: 1910-1910.
  • Oral presentation/proffered paper: Additional chromosomal abnormalities in chronic myeloid leukemia: lest we forget. Presented at ESMO (European society of Medical Oncology) Asia 2016, Singapore.
  • Oral presentation: Generic Imatinib in Chronic Myeloid Leukemia: Survival of the cheapest. Presented at ASH 2016 (Annual American Society of Hematology conference), San Diego.
  • Paper presentation at KAPICON 2012 – “ Microalbuminuric Anemia “ – A Study of the relationship between Hemoglobin levels and Albuminuria in Diabetes.
  • Obesity and breast cancer: Association of serum adiponectin, leptin and adiponectin-leptin ratio as risk biomarkers. Presented at Annual Indian Society of Medical and Pediatric Oncology conference, 2016 at Delhi
  • Renal Reversibility in multiple myeloma: A race against the clock! Presented at Myeloma: State of the art, 2016, PGI Chandigarh
  • Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care centre in India. Presented at Annual Asian Clinical Oncology society conference 2016, Delhi
  • Validation of an enhanced International Prognostic Index (NCCN-IPI) in patients with diffuse large B cell lymphoma in the Rituximab era: 7 years’ experience from a tertiary care centre in South India. Presented at ICON 2016.
  • Frontline Imatinib in chronic myeloid leukemia: a jewel in the crown, Presented at Hematocon 2016, Jaipur
  • Pediatric chronic myeloid leukemia: wise to generalize? Presented at ISMPOCON 2016, Delhi
  • Poster presentation at HEMATOCON 2015 - Monosomy 7 and Deletion 7q in Acute Myeloid Leukemia – M0/M1 with prior Myelodysplastic syndrome transformed from Fanconi Anemia – a case report
  • Poster presentation at APICON 2013 (National Conference) - Phenytoin induced Cerebellar Ataxia and Orofacial Dyskinesia in a rare case of Disseminated Cysticercosis.

    Languages Spoken

  • Telugu
  • English
  • Hindi
  • Kannada
  • Tamil
  • Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • Collaborative Medical Oncology Group (CMOG)
  • Medical Oncology Forum (MOF)
  • American Society of Clinical Oncology (ASCO)
  • Field of Expertise

  • Blood cancers (Acute lymphoblastic leukemia, Acute myeloid leukemia, chronic myeloid leukemia, Chronic lymphocytic leukemia), Plasma cell disorders
  • Autologous and Allogeneic stem cell transplants (matched sibling donor, matched/mismatched unrelated donor, haploidentical donor, cord blood transplants). Trained at Vancouver General Hospital, British Columbia that performs more than 300 stem cell transplants a year.
  • Childhood cancers
  • Immunotherapy
  • Targeted therapy
  • Awards & Achievements

  • University Topper (SDUAHER) Internal Medicine (2013).
  • 1st rank DM Medical Oncology Entrance Examination – Nizam’s Institute of Medical Sciences.
  • Oral presentation short-listed for the prestigious best of Annual American Society of Hematology Conference, San Diego, 2016
  • Best poster presentation award at ICON 2016
  • ICON 2017, Lucknow: Quiz (2nd Prize)
  • ISMPO-Torrent Young Scholar Award 2017, entered zonal round, Chennai.
  • Talks & Publications

  • Danthala M, Kallur KG, Prashant GR, Rajkumar K, Rao MR. 177 Lu-DOTATATE therapy in patients with neuroendocrine tumours: 5 years’ experience from a tertiary cancer care centre in India. European journal of nuclear medicine and molecular imaging. 2014 Jul 1;41(7):1319-26.
  • Danthala M, Gundeti S, Kuruva SP, Puligundla KC, Adusumilli P, Karnam AP, Bala S, Konatam ML, Maddali LS, Digumarti RR. Generic imatinib in chronic myeloid leukemia: survival of the cheapest. Clinical Lymphoma Myeloma and Leukemia. 2017 Jul 1;17(7):457-62.
  • Danthala M, Gundeti S, Maddali LS, Pillai A, Puligundla KC, Adusumilli RP. Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care center in India. South Asian journal of cancer. 2016 Oct;5(4):176.
  • Danthala M, Rajesh GR, Gundeti S, Raju GS, Chandran P, Srinivas ML. Obesity and breast cancer: Association of serum adiponectin, leptin, and adiponectin–leptin ratio as risk biomarkers. Indian Journal of Medical and Paediatric Oncology. 2018 Jul 1;39(3):292.
  • Danthala M, Lakshmaiah V. Correlative study of serum cystatin C levels with severity of acute ischemic stroke. Journal of Clinical and Biomedical Sciences J Clin Biomed Sci. 2013;3(4):188-92.
  • Karpurmath SV, Seshachalam A, Selvaraj K, Rajamani P, Reddy N, Malipatil B, Sirigeri R, Prasad K, Reddy K, Danthala M, Udupa KS. Halving time of BCR-ABL1 in Chronic Myeloid Leukemia, Is it a better than day 90 value–Multicenter study from south India. Clinical Lymphoma Myeloma and Leukemia. 2019 Sep 30.
  • Seshachalam A, Karpurmath SV, Rathnam K, Raman SG, Janarthinakani M, Prasad K, Patil C, Anoop P, Reddy N, Anumula SK, Roopa SP, Danthala M. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. Journal of global oncology. 2019 Dec;5:1-3.
  • Adusumilli P, Gundeti S, Danthala M, Pk C. 301P Long term survival and late side effects of paediatric Hodgkin lymphoma patients: a study from tertiary care centre in Southern India. Annals of Oncology. 2015 Dec 1;26(suppl_9):ix89-.
  • Puligundla CK, Gundeti S, Bala S, Pillai A, Adusumilli P, Danthala M, Konatam ML, Maddali LS. Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domain in CML Patients with Imatinib Treatment Failure-Data from a Large Tertiary Center in India. Blood 2016 vol: 128 (22) pp: 1910-1910.
  • Oral presentation/proffered paper: Additional chromosomal abnormalities in chronic myeloid leukemia: lest we forget. Presented at ESMO (European society of Medical Oncology) Asia 2016, Singapore.
  • Oral presentation: Generic Imatinib in Chronic Myeloid Leukemia: Survival of the cheapest. Presented at ASH 2016 (Annual American Society of Hematology conference), San Diego.
  • Paper presentation at KAPICON 2012 – “ Microalbuminuric Anemia “ – A Study of the relationship between Hemoglobin levels and Albuminuria in Diabetes.
  • Obesity and breast cancer: Association of serum adiponectin, leptin and adiponectin-leptin ratio as risk biomarkers. Presented at Annual Indian Society of Medical and Pediatric Oncology conference, 2016 at Delhi
  • Renal Reversibility in multiple myeloma: A race against the clock! Presented at Myeloma: State of the art, 2016, PGI Chandigarh
  • Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care centre in India. Presented at Annual Asian Clinical Oncology society conference 2016, Delhi
  • Validation of an enhanced International Prognostic Index (NCCN-IPI) in patients with diffuse large B cell lymphoma in the Rituximab era: 7 years’ experience from a tertiary care centre in South India. Presented at ICON 2016.
  • Frontline Imatinib in chronic myeloid leukemia: a jewel in the crown, Presented at Hematocon 2016, Jaipur
  • Pediatric chronic myeloid leukemia: wise to generalize? Presented at ISMPOCON 2016, Delhi
  • Poster presentation at HEMATOCON 2015 - Monosomy 7 and Deletion 7q in Acute Myeloid Leukemia – M0/M1 with prior Myelodysplastic syndrome transformed from Fanconi Anemia – a case report
  • Poster presentation at APICON 2013 (National Conference) - Phenytoin induced Cerebellar Ataxia and Orofacial Dyskinesia in a rare case of Disseminated Cysticercosis.

    Field of Expertise

  • Blood cancers (Acute lymphoblastic leukemia, Acute myeloid leukemia, chronic myeloid leukemia, Chronic lymphocytic leukemia), Plasma cell disorders
  • Autologous and Allogeneic stem cell transplants (matched sibling donor, matched/mismatched unrelated donor, haploidentical donor, cord blood transplants). Trained at Vancouver General Hospital, British Columbia that performs more than 300 stem cell transplants a year.
  • Childhood cancers
  • Immunotherapy
  • Targeted therapy
  • Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • Collaborative Medical Oncology Group (CMOG)
  • Medical Oncology Forum (MOF)
  • American Society of Clinical Oncology (ASCO)
  • Languages Spoken

  • Telugu
  • English
  • Hindi
  • Kannada
  • Tamil
  • Awards & Achievements

  • University Topper (SDUAHER) Internal Medicine (2013).
  • 1st rank DM Medical Oncology Entrance Examination – Nizam’s Institute of Medical Sciences.
  • Oral presentation short-listed for the prestigious best of Annual American Society of Hematology Conference, San Diego, 2016
  • Best poster presentation award at ICON 2016
  • ICON 2017, Lucknow: Quiz (2nd Prize)
  • ISMPO-Torrent Young Scholar Award 2017, entered zonal round, Chennai.
  • Talks & Publications

  • Danthala M, Kallur KG, Prashant GR, Rajkumar K, Rao MR. 177 Lu-DOTATATE therapy in patients with neuroendocrine tumours: 5 years’ experience from a tertiary cancer care centre in India. European journal of nuclear medicine and molecular imaging. 2014 Jul 1;41(7):1319-26.
  • Danthala M, Gundeti S, Kuruva SP, Puligundla KC, Adusumilli P, Karnam AP, Bala S, Konatam ML, Maddali LS, Digumarti RR. Generic imatinib in chronic myeloid leukemia: survival of the cheapest. Clinical Lymphoma Myeloma and Leukemia. 2017 Jul 1;17(7):457-62.
  • Danthala M, Gundeti S, Maddali LS, Pillai A, Puligundla KC, Adusumilli RP. Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care center in India. South Asian journal of cancer. 2016 Oct;5(4):176.
  • Danthala M, Rajesh GR, Gundeti S, Raju GS, Chandran P, Srinivas ML. Obesity and breast cancer: Association of serum adiponectin, leptin, and adiponectin–leptin ratio as risk biomarkers. Indian Journal of Medical and Paediatric Oncology. 2018 Jul 1;39(3):292.
  • Danthala M, Lakshmaiah V. Correlative study of serum cystatin C levels with severity of acute ischemic stroke. Journal of Clinical and Biomedical Sciences J Clin Biomed Sci. 2013;3(4):188-92.
  • Karpurmath SV, Seshachalam A, Selvaraj K, Rajamani P, Reddy N, Malipatil B, Sirigeri R, Prasad K, Reddy K, Danthala M, Udupa KS. Halving time of BCR-ABL1 in Chronic Myeloid Leukemia, Is it a better than day 90 value–Multicenter study from south India. Clinical Lymphoma Myeloma and Leukemia. 2019 Sep 30.
  • Seshachalam A, Karpurmath SV, Rathnam K, Raman SG, Janarthinakani M, Prasad K, Patil C, Anoop P, Reddy N, Anumula SK, Roopa SP, Danthala M. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. Journal of global oncology. 2019 Dec;5:1-3.
  • Adusumilli P, Gundeti S, Danthala M, Pk C. 301P Long term survival and late side effects of paediatric Hodgkin lymphoma patients: a study from tertiary care centre in Southern India. Annals of Oncology. 2015 Dec 1;26(suppl_9):ix89-.
  • Puligundla CK, Gundeti S, Bala S, Pillai A, Adusumilli P, Danthala M, Konatam ML, Maddali LS. Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domain in CML Patients with Imatinib Treatment Failure-Data from a Large Tertiary Center in India. Blood 2016 vol: 128 (22) pp: 1910-1910.
  • Oral presentation/proffered paper: Additional chromosomal abnormalities in chronic myeloid leukemia: lest we forget. Presented at ESMO (European society of Medical Oncology) Asia 2016, Singapore.
  • Oral presentation: Generic Imatinib in Chronic Myeloid Leukemia: Survival of the cheapest. Presented at ASH 2016 (Annual American Society of Hematology conference), San Diego.
  • Paper presentation at KAPICON 2012 – “ Microalbuminuric Anemia “ – A Study of the relationship between Hemoglobin levels and Albuminuria in Diabetes.
  • Obesity and breast cancer: Association of serum adiponectin, leptin and adiponectin-leptin ratio as risk biomarkers. Presented at Annual Indian Society of Medical and Pediatric Oncology conference, 2016 at Delhi
  • Renal Reversibility in multiple myeloma: A race against the clock! Presented at Myeloma: State of the art, 2016, PGI Chandigarh
  • Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care centre in India. Presented at Annual Asian Clinical Oncology society conference 2016, Delhi
  • Validation of an enhanced International Prognostic Index (NCCN-IPI) in patients with diffuse large B cell lymphoma in the Rituximab era: 7 years’ experience from a tertiary care centre in South India. Presented at ICON 2016.
  • Frontline Imatinib in chronic myeloid leukemia: a jewel in the crown, Presented at Hematocon 2016, Jaipur
  • Pediatric chronic myeloid leukemia: wise to generalize? Presented at ISMPOCON 2016, Delhi
  • Poster presentation at HEMATOCON 2015 - Monosomy 7 and Deletion 7q in Acute Myeloid Leukemia – M0/M1 with prior Myelodysplastic syndrome transformed from Fanconi Anemia – a case report
  • Poster presentation at APICON 2013 (National Conference) - Phenytoin induced Cerebellar Ataxia and Orofacial Dyskinesia in a rare case of Disseminated Cysticercosis.

    Awards & Achievements

  • University Topper (SDUAHER) Internal Medicine (2013).
  • 1st rank DM Medical Oncology Entrance Examination – Nizam’s Institute of Medical Sciences.
  • Oral presentation short-listed for the prestigious best of Annual American Society of Hematology Conference, San Diego, 2016
  • Best poster presentation award at ICON 2016
  • ICON 2017, Lucknow: Quiz (2nd Prize)
  • ISMPO-Torrent Young Scholar Award 2017, entered zonal round, Chennai.
  • Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • Collaborative Medical Oncology Group (CMOG)
  • Medical Oncology Forum (MOF)
  • American Society of Clinical Oncology (ASCO)
  • Languages Spoken

  • Telugu
  • English
  • Hindi
  • Kannada
  • Tamil
  • Field of Expertise

  • Blood cancers (Acute lymphoblastic leukemia, Acute myeloid leukemia, chronic myeloid leukemia, Chronic lymphocytic leukemia), Plasma cell disorders
  • Autologous and Allogeneic stem cell transplants (matched sibling donor, matched/mismatched unrelated donor, haploidentical donor, cord blood transplants). Trained at Vancouver General Hospital, British Columbia that performs more than 300 stem cell transplants a year.
  • Childhood cancers
  • Immunotherapy
  • Targeted therapy
  • Talks & Publications

  • Danthala M, Kallur KG, Prashant GR, Rajkumar K, Rao MR. 177 Lu-DOTATATE therapy in patients with neuroendocrine tumours: 5 years’ experience from a tertiary cancer care centre in India. European journal of nuclear medicine and molecular imaging. 2014 Jul 1;41(7):1319-26.
  • Danthala M, Gundeti S, Kuruva SP, Puligundla KC, Adusumilli P, Karnam AP, Bala S, Konatam ML, Maddali LS, Digumarti RR. Generic imatinib in chronic myeloid leukemia: survival of the cheapest. Clinical Lymphoma Myeloma and Leukemia. 2017 Jul 1;17(7):457-62.
  • Danthala M, Gundeti S, Maddali LS, Pillai A, Puligundla KC, Adusumilli RP. Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care center in India. South Asian journal of cancer. 2016 Oct;5(4):176.
  • Danthala M, Rajesh GR, Gundeti S, Raju GS, Chandran P, Srinivas ML. Obesity and breast cancer: Association of serum adiponectin, leptin, and adiponectin–leptin ratio as risk biomarkers. Indian Journal of Medical and Paediatric Oncology. 2018 Jul 1;39(3):292.
  • Danthala M, Lakshmaiah V. Correlative study of serum cystatin C levels with severity of acute ischemic stroke. Journal of Clinical and Biomedical Sciences J Clin Biomed Sci. 2013;3(4):188-92.
  • Karpurmath SV, Seshachalam A, Selvaraj K, Rajamani P, Reddy N, Malipatil B, Sirigeri R, Prasad K, Reddy K, Danthala M, Udupa KS. Halving time of BCR-ABL1 in Chronic Myeloid Leukemia, Is it a better than day 90 value–Multicenter study from south India. Clinical Lymphoma Myeloma and Leukemia. 2019 Sep 30.
  • Seshachalam A, Karpurmath SV, Rathnam K, Raman SG, Janarthinakani M, Prasad K, Patil C, Anoop P, Reddy N, Anumula SK, Roopa SP, Danthala M. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. Journal of global oncology. 2019 Dec;5:1-3.
  • Adusumilli P, Gundeti S, Danthala M, Pk C. 301P Long term survival and late side effects of paediatric Hodgkin lymphoma patients: a study from tertiary care centre in Southern India. Annals of Oncology. 2015 Dec 1;26(suppl_9):ix89-.
  • Puligundla CK, Gundeti S, Bala S, Pillai A, Adusumilli P, Danthala M, Konatam ML, Maddali LS. Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domain in CML Patients with Imatinib Treatment Failure-Data from a Large Tertiary Center in India. Blood 2016 vol: 128 (22) pp: 1910-1910.
  • Oral presentation/proffered paper: Additional chromosomal abnormalities in chronic myeloid leukemia: lest we forget. Presented at ESMO (European society of Medical Oncology) Asia 2016, Singapore.
  • Oral presentation: Generic Imatinib in Chronic Myeloid Leukemia: Survival of the cheapest. Presented at ASH 2016 (Annual American Society of Hematology conference), San Diego.
  • Paper presentation at KAPICON 2012 – “ Microalbuminuric Anemia “ – A Study of the relationship between Hemoglobin levels and Albuminuria in Diabetes.
  • Obesity and breast cancer: Association of serum adiponectin, leptin and adiponectin-leptin ratio as risk biomarkers. Presented at Annual Indian Society of Medical and Pediatric Oncology conference, 2016 at Delhi
  • Renal Reversibility in multiple myeloma: A race against the clock! Presented at Myeloma: State of the art, 2016, PGI Chandigarh
  • Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care centre in India. Presented at Annual Asian Clinical Oncology society conference 2016, Delhi
  • Validation of an enhanced International Prognostic Index (NCCN-IPI) in patients with diffuse large B cell lymphoma in the Rituximab era: 7 years’ experience from a tertiary care centre in South India. Presented at ICON 2016.
  • Frontline Imatinib in chronic myeloid leukemia: a jewel in the crown, Presented at Hematocon 2016, Jaipur
  • Pediatric chronic myeloid leukemia: wise to generalize? Presented at ISMPOCON 2016, Delhi
  • Poster presentation at HEMATOCON 2015 - Monosomy 7 and Deletion 7q in Acute Myeloid Leukemia – M0/M1 with prior Myelodysplastic syndrome transformed from Fanconi Anemia – a case report
  • Poster presentation at APICON 2013 (National Conference) - Phenytoin induced Cerebellar Ataxia and Orofacial Dyskinesia in a rare case of Disseminated Cysticercosis.

    Talks & Publications

  • Danthala M, Kallur KG, Prashant GR, Rajkumar K, Rao MR. 177 Lu-DOTATATE therapy in patients with neuroendocrine tumours: 5 years’ experience from a tertiary cancer care centre in India. European journal of nuclear medicine and molecular imaging. 2014 Jul 1;41(7):1319-26.
  • Danthala M, Gundeti S, Kuruva SP, Puligundla KC, Adusumilli P, Karnam AP, Bala S, Konatam ML, Maddali LS, Digumarti RR. Generic imatinib in chronic myeloid leukemia: survival of the cheapest. Clinical Lymphoma Myeloma and Leukemia. 2017 Jul 1;17(7):457-62.
  • Danthala M, Gundeti S, Maddali LS, Pillai A, Puligundla KC, Adusumilli RP. Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care center in India. South Asian journal of cancer. 2016 Oct;5(4):176.
  • Danthala M, Rajesh GR, Gundeti S, Raju GS, Chandran P, Srinivas ML. Obesity and breast cancer: Association of serum adiponectin, leptin, and adiponectin–leptin ratio as risk biomarkers. Indian Journal of Medical and Paediatric Oncology. 2018 Jul 1;39(3):292.
  • Danthala M, Lakshmaiah V. Correlative study of serum cystatin C levels with severity of acute ischemic stroke. Journal of Clinical and Biomedical Sciences J Clin Biomed Sci. 2013;3(4):188-92.
  • Karpurmath SV, Seshachalam A, Selvaraj K, Rajamani P, Reddy N, Malipatil B, Sirigeri R, Prasad K, Reddy K, Danthala M, Udupa KS. Halving time of BCR-ABL1 in Chronic Myeloid Leukemia, Is it a better than day 90 value–Multicenter study from south India. Clinical Lymphoma Myeloma and Leukemia. 2019 Sep 30.
  • Seshachalam A, Karpurmath SV, Rathnam K, Raman SG, Janarthinakani M, Prasad K, Patil C, Anoop P, Reddy N, Anumula SK, Roopa SP, Danthala M. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. Journal of global oncology. 2019 Dec;5:1-3.
  • Adusumilli P, Gundeti S, Danthala M, Pk C. 301P Long term survival and late side effects of paediatric Hodgkin lymphoma patients: a study from tertiary care centre in Southern India. Annals of Oncology. 2015 Dec 1;26(suppl_9):ix89-.
  • Puligundla CK, Gundeti S, Bala S, Pillai A, Adusumilli P, Danthala M, Konatam ML, Maddali LS. Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domain in CML Patients with Imatinib Treatment Failure-Data from a Large Tertiary Center in India. Blood 2016 vol: 128 (22) pp: 1910-1910.
  • Oral presentation/proffered paper: Additional chromosomal abnormalities in chronic myeloid leukemia: lest we forget. Presented at ESMO (European society of Medical Oncology) Asia 2016, Singapore.
  • Oral presentation: Generic Imatinib in Chronic Myeloid Leukemia: Survival of the cheapest. Presented at ASH 2016 (Annual American Society of Hematology conference), San Diego.
  • Paper presentation at KAPICON 2012 – “ Microalbuminuric Anemia “ – A Study of the relationship between Hemoglobin levels and Albuminuria in Diabetes.
  • Obesity and breast cancer: Association of serum adiponectin, leptin and adiponectin-leptin ratio as risk biomarkers. Presented at Annual Indian Society of Medical and Pediatric Oncology conference, 2016 at Delhi
  • Renal Reversibility in multiple myeloma: A race against the clock! Presented at Myeloma: State of the art, 2016, PGI Chandigarh
  • Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care centre in India. Presented at Annual Asian Clinical Oncology society conference 2016, Delhi
  • Validation of an enhanced International Prognostic Index (NCCN-IPI) in patients with diffuse large B cell lymphoma in the Rituximab era: 7 years’ experience from a tertiary care centre in South India. Presented at ICON 2016.
  • Frontline Imatinib in chronic myeloid leukemia: a jewel in the crown, Presented at Hematocon 2016, Jaipur
  • Pediatric chronic myeloid leukemia: wise to generalize? Presented at ISMPOCON 2016, Delhi
  • Poster presentation at HEMATOCON 2015 - Monosomy 7 and Deletion 7q in Acute Myeloid Leukemia – M0/M1 with prior Myelodysplastic syndrome transformed from Fanconi Anemia – a case report
  • Poster presentation at APICON 2013 (National Conference) - Phenytoin induced Cerebellar Ataxia and Orofacial Dyskinesia in a rare case of Disseminated Cysticercosis.
  • Awards & Achievements

  • University Topper (SDUAHER) Internal Medicine (2013).
  • 1st rank DM Medical Oncology Entrance Examination – Nizam’s Institute of Medical Sciences.
  • Oral presentation short-listed for the prestigious best of Annual American Society of Hematology Conference, San Diego, 2016
  • Best poster presentation award at ICON 2016
  • ICON 2017, Lucknow: Quiz (2nd Prize)
  • ISMPO-Torrent Young Scholar Award 2017, entered zonal round, Chennai.
  • Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • Collaborative Medical Oncology Group (CMOG)
  • Medical Oncology Forum (MOF)
  • American Society of Clinical Oncology (ASCO)
  • Languages Spoken

  • Telugu
  • English
  • Hindi
  • Kannada
  • Tamil
  • Field of Expertise

  • Blood cancers (Acute lymphoblastic leukemia, Acute myeloid leukemia, chronic myeloid leukemia, Chronic lymphocytic leukemia), Plasma cell disorders
  • Autologous and Allogeneic stem cell transplants (matched sibling donor, matched/mismatched unrelated donor, haploidentical donor, cord blood transplants). Trained at Vancouver General Hospital, British Columbia that performs more than 300 stem cell transplants a year.
  • Childhood cancers
  • Immunotherapy
  • Targeted therapy

Blogs

Who Needs A Stem Cell Transplant?

A bone marrow transplant also called stem cell transplant is a procedure that infuses healthy blood-forming stem cells in another person body to replace damaged or diseased bone marrow. Stem cell transplants are reserved for patients with life-threatening diseases whose blood, bone marrow, or immune system is compromised. Deciding whether you should agree to get a stem cell transplant can be overwhelming. Here are a few things to consider to help you make that decision.

The Bone Marrow, Stem Cells and Blood - In Health Disease

Bone Marrow: If you’ve ever seen a skeleton in a movie or a museum, you might presume that bones are just dry, hard and dead. This couldn’t be further from the truth. Hidden inside is the bone marrow – the soft, spongy, squishy jelly that harbours your stem cells. Stem cells: Stem cells are the foundation for every organ and tissue in your body. There are many different types of stem cells that come from different places in the body or are formed at different times in our lives.

Matchmaking - Donors In Stem Cell Transplants

Unlike blood donations, which can be given to the millions and millions of people who share the same blood type, stem cell donors are carefully matched to their recipients on a one-to-one basis.  The key to finding a good match is a set of molecules called Human Leukocyte Antigens (abbreviated as HLAs), which decorate the surface of peripheral blood stem cells and most other cells. It’s as if all of your cells share the same fingerprints. These “markers” distinguish your cells from potentially dangerous trespassers like viruses, bacteria, or cancer.

Emergency Contraception: Side-effects and Methods

Is unprotected sex turning into a nightmare? Is it raising unwanted doubts and increasing fear as the time tics away? Many women around the world face this situation. When such a moment in life arises, Emergency Contraception (EC) is a great fall back option or plan B to avert the unforeseen circumstances. Although the good old and the safest form of contraception is to have the protection on.  Unfortunately, sometimes things can go way out of hand and for all such times EC is the last resort.

App floating icon
Appointment
Health Check
Contact Us
Write to COO
Call Us